Recombinant multi-species OS9 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine OS9 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a protein that is highly expressed in osteosarcomas. This protein binds to the hypoxia-inducible factor 1 (HIF-1), a key regulator of the hypoxic response and angiogenesis, and promotes the degradation of one of its subunits. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]
The Alternative Names of target: 4632413K17Rik,Amplified in osteosarcoma 9,ERLEC2,OS-9,OS9,Os-9,Os9,Protein OS-9

Target products collectionGo to OS9 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-SE0390-Ag-1/ GM-Tg-hg-SE0390-Ag-2 Human OS9 protein Human
GM-Tg-rg-SE0390-Ag-1/ GM-Tg-rg-SE0390-Ag-2 Rat OS9 protein Rat
GM-Tg-mg-SE0390-Ag-1/ GM-Tg-mg-SE0390-Ag-2 Mouse OS9 protein Mouse
GM-Tg-cynog-SE0390-Ag-1/ GM-Tg-cynog-SE0390-Ag-2 Cynomolgus/Rhesus macaque OS9 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-SE0390-Ag-1/ GM-Tg-felg-SE0390-Ag-2 Feline OS9 protein Feline
GM-Tg-cang-SE0390-Ag-1/ GM-Tg-cang-SE0390-Ag-2 Canine OS9 protein Canine
GM-Tg-bovg-SE0390-Ag-1/ GM-Tg-bovg-SE0390-Ag-2 Bovine OS9 protein Bovine
GM-Tg-equg-SE0390-Ag-1/ GM-Tg-equg-SE0390-Ag-2 Equine OS9 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-SE0390-Ag-1/ GM-Tg-hg-SE0390-Ag-2; GM-Tg-rg-SE0390-Ag-1/ GM-Tg-rg-SE0390-Ag-2;
GM-Tg-mg-SE0390-Ag-1/ GM-Tg-mg-SE0390-Ag-2; GM-Tg-cynog-SE0390-Ag-1/ GM-Tg-cynog-SE0390-Ag-2;
GM-Tg-felg-SE0390-Ag-1/ GM-Tg-felg-SE0390-Ag-2; GM-Tg-cang-SE0390-Ag-1/ GM-Tg-cang-SE0390-Ag-2;
GM-Tg-bovg-SE0390-Ag-1/ GM-Tg-bovg-SE0390-Ag-2; GM-Tg-equg-SE0390-Ag-1/ GM-Tg-equg-SE0390-Ag-2
Products Name OS9 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name OS9
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine OS9 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.